The Long Read Sequencing Market Size is valued at USD 594.8 Mn in 2023 and is predicted to reach USD 4,571.3 Mn by the year 2031 at an 29.7% CAGR during the forecast period for 2024-2031.
Long-read sequencing is an advanced DNA sequencing technology that allows researchers to read longer sequences of DNA, surpassing the capabilities of traditional short-read methods. This technology is essential for deciphering complex genomic structures and variations that shorter reads often miss. It is particularly valuable in genomics, providing detailed insights into structural variations, repetitive regions, and long-range genomic information, which are critical for comprehensive genome analysis.
The applications of long-read sequencing are vast and span multiple fields. It is widely used in whole genome sequencing to provide a complete view of an organism's genetic makeup, epigenetics to study DNA modifications that affect gene expression, RNA sequencing to analyze the transcriptome, and complex population studies to investigate genetic diversity. Additionally, it is utilized in targeted sequencing, focusing on specific genes or regions, particularly in clinical diagnostics. The growing prevalence of genetic disorders is a key driving factor behind the expansion of the long-read sequencing market. As the demand for accurate and comprehensive genomic data increases, long-read sequencing's ability to identify rare genetic variants and structural changes associated with diseases like cancer is propelling its adoption in both research and clinical settings.
Competitive Landscape
Some of the Key Players in Long Read Sequencing:
- 10X Genomics, Inc.
- Agilent Technologies, Inc.
- Azenta US, Inc.
- BaseClear BV
- BGI Group
- CD Genomics
- Danaher Corporation
- EdenRoc Sciences
- Element Biosciences
- Grandomics
- Illumina, Inc.
- New England Biolabs
- Novogene Co., Ltd.
- Oxford Nanopore Technologies plc.
- PacBio
- QIAGEN
- Revvity, Inc.
- Sage Sciences, Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Cantata Bio
- FG Technologies
- GrandOmics
- MicrobesNG
- St Vincents Hospital Melbourne
Market Segmentation:
The long read sequencing market is segmented by offerings, technology, workflow, application, usage, end users. By offerings the market is segmented consumables, instruments, services. By technology market is categorized into nanopore sequencing, single-molecule real-time sequencing, synthetic long-read sequencing. By workflow market is categorized into sequencing, sample preparation, data analysis. By application the market is categorized into whole genome sequencing, targeted sequencing, metagenomics, epigenetics, whole exome sequencing, other applications. By usage market is categorized into research, clinical. By end users market is categorized into academic & research institutes, hospitals, clinics & diagnostic labs, pharmaceutical & biotechnology companies, other end users
Instruments Segment is Expected to Drive the Long Read Sequencing Market
The instruments segment is a key driver of the long-read sequencing market, fueled by advancements in technologies from companies like Pacific Biosciences (PacBio) and Oxford Nanopore Technologies. These sophisticated instruments enable longer DNA reads, crucial for accurately analyzing complex genomic regions and structural variations that short-read methods often miss. The growing demand for detailed genomic data in personalized medicine, cancer research, and genetic disorder diagnostics underscores the importance of these high-performance instruments. Their cost-effectiveness, real-time sequencing capabilities, and broad applicability across whole genome sequencing, epigenetics, and RNA sequencing further propel market growth by making long-read sequencing more accessible and efficient for academic and clinical use.
Nanopore Sequencing Is Growing At The Highest Rate In The Long Read Sequencing Market.
Nanopore sequencing is rapidly growing in the long-read sequencing market, driven by its real-time sequencing capabilities, versatility, and cost-effectiveness. It allows researchers to obtain immediate results, crucial for rapid decision-making in clinical diagnostics for infectious diseases and genetic disorders, while also enabling real-time monitoring and optimization of sequencing runs. Its versatility in sequencing both DNA and RNA opens applications in whole genome sequencing, targeted sequencing, metagenomics, and RNA sequencing, particularly for analyzing complex genomic regions and structural variants. Additionally, its lower operational costs and minimal sample preparation requirements make it an affordable and accessible option for a wide range of research and clinical laboratories, further fueling its adoption.
Regionally, North America Led the Long Read Sequencing Market.
North America's leadership in the long-read sequencing market is driven by its strong research infrastructure, increasing awareness and adoption, technological advancements, and significant investment in genomic research. The region is home to leading companies like Illumina, PacBio, and Oxford Nanopore Technologies, which are pioneering innovative sequencing technologies. Growing awareness of the comprehensive genomic insights provided by long-read sequencing is fueling demand among researchers and clinicians. Rapid advancements in technologies like nanopore and single-molecule real-time (SMRT) sequencing are enhancing the accessibility and effectiveness of these methods. Additionally, substantial investments from both public and private sectors in genomic research, particularly for personalized medicine and precision health, are further accelerating the adoption of long-read sequencing in North America.
Long Read Sequencing Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 594.8 Mn |
|
Revenue Forecast In 2031 |
USD 4,571.3 Mn |
|
Growth Rate CAGR |
CAGR of 29.7 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Offerings, Technology, Workflow, Application, Usage, End Users and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
10X Genomics, Inc., Agilent Technologies, Inc., Azenta US, Inc. , BaseClear BV, BGI Group, CD Genomics, Danaher Corporation, EdenRoc Sciences, Element Biosciences, Grandomics, Illumina, Inc., New England Biolabs, Novogene Co., Ltd., Oxford Nanopore Technologies plc., PacBio, QIAGEN, Revvity, Inc., Sage Sciences, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Cantata Bio, FG Technologies, GrandOmics, MicrobesNG, St Vincents Hospital Melbourne |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
